FORM 3

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934, Section 17(a) of the Public Utility Holding Company Act of 1935 or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL OMB Number: 3235-0104 Expires: January 31, 2005 Estimated average burden hours per response... 0.5

(Print or Type Responses)

1. Name and Address of Reporting Person *   LEVINE ARNOLD J 2. Date of Event Requiring Statement (Month/Day/Year) 11/21/2008 3. Issuer Name and Ticker or Trading Symbol Life Technologies Corp [LIFE] (Last) (First) (Middle) 5791 VAN ALLEN WAY 4. Relationship of Reporting Person(s) to Issuer (Check all applicable) __X__ Director _____ 10% Owner _____ Officer (give title below) _____ Other (specify below) 5. If Amendment, Date Original Filed(Month/Day/Year) (Street) CARLSBAD, CA 92008 6. Individual or Joint/Group Filing(Check Applicable Line) _X_ Form filed by One Reporting Person ___ Form filed by More than One Reporting Person (City) (State) (Zip) Table I - Non-Derivative Securities Beneficially Owned

1.Title of Security (Instr. 4) 2. Amount of Securities Beneficially Owned (Instr. 4) 3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5) 4. Nature of Indirect Beneficial Ownership (Instr. 5)

Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.			SEC 1473 (7-02)
	Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB control number.

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)

1. Title of Derivative Security (Instr. 4)	2. Date Exercisable and Expiration Date (Month/Day/Year)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form of Derivative Security: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Non-Qualified Stock Options (1) (12)	11/21/2008	01/21/2009	Common Stock	5,218	$ 24.46	D	Â
Non-Qualified Stock Options (2)	11/21/2008	10/21/2009	Common Stock	5,218	$ 41.09	D	Â
Non-Qualified Stock Options (3)	11/21/2008	10/19/2009	Common Stock	5,218	$ 124.53	D	Â
Non-Qualified Stock Options (4)	11/21/2008	10/18/2011	Common Stock	6,958	$ 32.17	D	Â
Non-Qualified Stock Options (5)	11/21/2008	10/17/2012	Common Stock	6,958	$ 23	D	Â
Non-Qualified Stock Options (6)	11/21/2008	10/16/2013	Common Stock	6,523	$ 26.7	D	Â
Non-Qualified Stock Options (7)	11/21/2008	10/21/2014	Common Stock	8,002	$ 21.74	D	Â
Non-Qualified Stock Options (8)	11/21/2008	10/20/2015	Common Stock	7,828	$ 26.74	D	Â
Non-Qualified Stock Options (9)	11/21/2008	10/19/2016	Common Stock	7,828	$ 38.8	D	Â
Non-Qualified Stock Options (10)	11/21/2008	10/18/2017	Common Stock	7,828	$ 41.38	D	Â
Deferred Stock Units (11)	11/21/2008	11/21/2018	Common Stock	25,756	$ 0	D	Â

Reporting Owners

Reporting Owner Name / Address	Relationships
	Director	10% Owner	Officer	Other
LEVINE ARNOLD J 5791 VAN ALLEN WAY CARLSBAD, CA 92008	  X	Â	Â	Â

Signatures

/s/ Joseph W. Secondine, Jr. POA		11/25/2008
**Signature of Reporting Person		Date

Explanation of Responses:

*	If the form is filed by more than one reporting person, see Instruction 5(b)(v).
**	Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
(1)	NQSO grant # 08959. Shares converted to LIFE as a result of the Applied Biosystems merger with Invitrogen Corporation (name subsequently changed to Life Technologies).
(2)	NQSO grant #00001996. Shares converted to LIFE as a result of the Applied Biosystems merger with Invitrogen Corporation (name subsequently changed to Life Technologies).
(3)	NQSO grant #00006285. Shares converted to LIFE as a result of the Applied Biosystems merger with Invitrogen Corporation (name subsequently changed to Life Technologies).
(4)	NQSO grant #00010306. Shares converted to LIFE as a result of the Applied Biosystems merger with Invitrogen Corporation (name subsequently changed to Life Technologies).
(5)	NQSO grant #00015172. Shares converted to LIFE as a result of the Applied Biosystems merger with Invitrogen Corporation (name subsequently changed to Life Technologies).
(6)	NQSO grant #00019798. Shares converted to LIFE as a result of the Applied Biosystems merger with Invitrogen Corporation (name subsequently changed to Life Technologies).
(7)	NQSO grant #00022270. Shares converted to LIFE as a result of the Applied Biosystems merger with Invitrogen Corporation (name subsequently changed to Life Technologies).
(8)	NQSO grant #D0014427. Shares converted to LIFE as a result of the Applied Biosystems merger with Invitrogen Corporation (name subsequently changed to Life Technologies).
(9)	NQSO grant #D0015409. Shares converted to LIFE as a result of the Applied Biosystems merger with Invitrogen Corporation (name subsequently changed to Life Technologies).
(10)	NQSO grant #19736. Shares converted to LIFE as a result of the Applied Biosystems merger with Invitrogen Corporation (name subsequently changed to Life Technologies).
(11)	Granted in lieu of director compensation or due to deferral of receipt of vested director grants.
(12)	The individual may hold additional shares acquired as a result of the conversion from Applied Biosystems stock to Life Technologies stock. Administration of the conversion is not complete. If it is determined that the individual owns shares, a Form 4A will be filed.

Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, See Instruction 6 for procedure.

Potential persons who are to respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB number.